Vanadium Single-Atom Nanozyme Boosts Cuproptosis/Ferroptosis/Apoptosis Combined with Photothermal-Enhanced Tumor Therapy through Dual Catalytic Activity
ACS Applied Bio Materials · 2025
DOI: 10.1021/acsabm.5c01512 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Bio Materials, 2025. Verfasst von Jie Ma und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei 230022, Anhui, China. Hauptthemen laut MEDLINE: Antineoplastic Agents, Biocompatible Materials, Vanadium. Die Arbeit nennt 33 Literaturangaben. Gefördert von: Natural Science Foundation of Anhui Province, Anhui Province Health Commission.
Abstract (Originalsprache)
Nanocatalysts hold significant promise in tumor therapy by facilitating the production of reactive oxygen species (ROS) within the tumor microenvironment (TME). Among these, single-atom nanozymes (SAzymes) stand out due to their atomically dispersed active sites, offering a viable alternative to natural enzymes. SAzyme can simulate the catalytic mechanisms of natural enzymes, such as peroxidase and catalase, achieving highly efficient biocatalytic effects. Moreover, they can maintain high catalytic activity and structural stability under extreme conditions. However, the application of SAzymes in anticancer treatments is still in its initial stages, necessitating further research and development. In this study, we have synthesized a single-atom catalytic enzymes with V2O5 coordination (vanadium-based single-atom catalysts, V-SAC) utilizing the electrospinning technique to enhance tumor suppression. The V-SAC demonstrates notable dual enzymatic activities, mimicking both peroxidase and glutathione peroxidase functions. It catalyzes the conversion of endogenous H2O2 to ·OH within the acidic tumor microenvironment, while simultaneously depleting glutathione (GSH). Significantly, V-SAC induces cuproptosis/ferroptosis/apoptosis, which further augments the efficacy of tumor treatment. Additionally, the exceptional photothermal properties of V-SAC enable photothermal therapy (PTT) for tumors. In vivo experiments reveal that V-SAC exhibits excellent antitumor capabilities coupled with high safety, underscoring its substantial potential for clinical applications in cancer treatment. These findings highlight the development of high-performance, biological safety single-atom catalysts for biomedical applications in tumor therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Thoracic Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei 230022, Anhui, China.
- Department of Thoracic Surgery, Anhui Chest Hospital, Hefei 230022, Anhui, China.
- School of Life Sciences, Anhui University, Hefei 230601, Anhui, China.
- School of Materials Science and Engineering, Anhui University, Hefei 230601, Anhui, China.
ORCID-Profile: Kangliang Sheng, Shan Gao
Förderung
- Natural Science Foundation of Anhui Province
- Anhui Province Health Commission
Zitieren
APA
Ma, J., Dang, X., Xue, Y., Yin, Z., Sheng, Y., Luo, R., Zhu, X., Sheng, K., Gao, S., & Zhang, R. (2025). Vanadium Single-Atom Nanozyme Boosts Cuproptosis/Ferroptosis/Apoptosis Combined with Photothermal-Enhanced Tumor Therapy through Dual Catalytic Activity. ACS Applied Bio Materials. https://doi.org/10.1021/acsabm.5c01512
Vancouver
Ma J, Dang X, Xue Y, Yin Z, Sheng Y, Luo R, et al. Vanadium Single-Atom Nanozyme Boosts Cuproptosis/Ferroptosis/Apoptosis Combined with Photothermal-Enhanced Tumor Therapy through Dual Catalytic Activity. ACS Applied Bio Materials. 2025. doi:10.1021/acsabm.5c01512
BibTeX
@article{Ma2025,
author = {Ma, Jie and Dang, Xinhao and Xue, Yan and Yin, Zihuan and Sheng, Yi and Luo, Ruixing and Zhu, Xueying and Sheng, Kangliang and Gao, Shan and Zhang, Renquan},
title = {Vanadium Single-Atom Nanozyme Boosts Cuproptosis/Ferroptosis/Apoptosis Combined with Photothermal-Enhanced Tumor Therapy through Dual Catalytic Activity},
journal = {ACS Applied Bio Materials},
year = {2025},
doi = {10.1021/acsabm.5c01512}
}
EUVIMED